Sign inGet started

Galson Steven K

Insider CIK 1495328 · VNDA Director · BCRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BCRX BIOCRYST PHARMACEUTICALS I A Award deriv2026-06-112026-06-1533,540— $033,540SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award2026-06-112026-06-1515,294— $027,794SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award deriv2025-06-122025-06-1627,181— $027,181SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award2025-06-122025-06-1612,500— $024,991SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award deriv2024-06-122024-06-1449,933— $049,933SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award2024-06-122024-06-146,820— $036,431SEC↗
BCRX BIOCRYST PHARMACEUTICALS I P Buy2024-05-132024-05-1521,940$5.49 $120.5K51,551SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award deriv2023-06-132023-06-1539,072— $039,072SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award2023-06-132023-06-1516,745— $029,611SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award deriv2022-06-072022-06-0930,022— $030,022SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award2022-06-072022-06-0912,866— $012,866SEC↗
BCRX BIOCRYST PHARMACEUTICALS I A Award deriv2021-09-012021-09-0260,000— $060,000SEC↗
VNDA Vanda Pharmaceuticals Inc. A Award deriv2014-05-222014-05-2715,000— $015,000SEC↗
VNDA Vanda Pharmaceuticals Inc. A Award deriv2013-06-202013-06-2415,000— $015,000SEC↗
VNDA Vanda Pharmaceuticals Inc. A Award deriv2012-06-142012-06-1815,000— $015,000SEC↗